麻豆传媒

SURTAVI: TAVR Matches Surgery in Lowest-Risk Cohort

But reinterventions, parvalvular regurgitation, and pacemaker implants mar a supposed victory

Mar 17, 2017

FOURIER Opens ACC With a Bang

Big LDL reduction, prevents MI, but with big price tag

Mar 17, 2017

Study: Erectile Dysfunction Drugs Safe After MI

Outcomes actually better among users in Swedish database

Mar 09, 2017

ACC: Looking Beyond Statins in LDL Lowering

New ACC guidance maps a path

Jun 10, 2016

ACC: Placebo Challenge for Statin Intolerance?

Cardiologists debate whether strategy might work in the clinic too

Apr 07, 2016

ACC: No Benefit for Beta-Blocker Before PCI

IV metoprolol was safe, but disappointing

Apr 05, 2016

CNN Calls Out 'Cataract Risk' in HOPE-3

Statins and cataracts: So what?

Apr 04, 2016

ACC: After a Decade, CABG Pulls Ahead of Meds for HF

Life-saving benefit of CABG now clear in long-term trial follow-up

Apr 04, 2016

Entresto: Why Is There Silence? We're Not Selling iPhones

The drug hailed as a true PARADIGM shift, is slow out of the gate

Apr 04, 2016

ACC: Evolocumab May Be Best Option for Statin Intolerance

Far greater LDL reduction but still some muscle complaints in GAUSS-3 trial

Apr 03, 2016

ACC: TAVR Once Again Non-Inferior to Surgery

No excess stroke or mortality at 2 years in lowest risk trial population yet studied

Apr 02, 2016

ACC: HOPE Results Boost Statin Prevention Role

Mortality and nonfatal events reduced

Apr 02, 2016

ACC: Folate Supplements Cut Strokes in Hypertension

Hypertensive patients with low blood folate levels gain big benefit.

Mar 19, 2015

ACC: Metformin No Help in MI Recovery

WASHINGTON -- Metformin started soon after reperfusion in the acute setting didn't help cardiac function recover in nondiabetic heart attack patients, a trial showed.

Mar 31, 2014

ACC: Gout Drug Tames the Heart

WASHINGTON -- Colchicine may be as effective at reducing multiple recurrences of pericarditis as it is in treating acute episodes and first recurrences.

Mar 30, 2014

ACC: Still No Clear CHOICE for TAVI

WASHINGTON -- Head-to-head comparison of transcatheter aortic valve implantation (TAVI) devices favored the second-generation Sapien XT over CoreValve, although the trial was criticized on several fronts.

Mar 30, 2014

ACC: CoreValve Bests Surgery

WASHINGTON -- Transcatheter aortic valve implantation (TAVI) with the CoreValve device improved survival compared with surgery in the high-risk pivotal trial cohort.

Mar 29, 2014

ACC: Statins Tied to Boost in Men's Sexual Function

WASHINGTON -- Statins appeared to improve erectile function to a clinically meaningful degree, according to a meta-analysis.

Mar 29, 2014

ACC: Is Chelation Plus Vitamins a Winning Combo?

SAN FRANCISCO -- Vitamins alone won't improve outcomes for patients who've had a heart attack, but they do appear to have additive benefits when given in conjunction with controversial chelation therapy, researchers reported here.

Mar 10, 2013

ACC: Triglycerides Decreased with Rosuvastatin Therapy

ATLANTA -- In a study that specifically scrutinized the effects of statin therapy on triglycerides, researchers said that rosuvastatin (Crestor) significantly reduced the blood lipid that has been linked to coronary artery disease better than placebo.

Mar 15, 2010

ACC: Clopidogrel Black Box Likely to Have Immediate Clinical Impact

ATLANTA -- The FDA's decision to add a black box warning to the label of clopidogrel (Plavix) came without warning to doctors attending the American College of Cardiology meeting here. But getting the word out to more than 13,000 cardiologists gathered in this city not an easy task.

Mar 14, 2010

ACC: FDA Announces Review of ACCORD Data

ATLANTA -- The FDA said it will conduct a full review of findings from a study which concluded that neither aggressive lipid-lowering therapy nor tight blood pressure control reduced cardiovascular events in persons with diabetes.

Mar 14, 2010

ACC: Senate Probe Finds Evidence that Drug Firms Worked to Delay ENHANCE Results

CHICAGO -- E-mails made public today described outrage more than a year ago by the ENHANCE trial's principal investigator because he perceived that a drugmaker was withholding bad results about ezetimibe/simvastatin (Vytorin) for non-scientific reasons.

Mar 31, 2008

ACC: Coronary Artery Disease Patients Should Have Low LDL Goal

ATLANTA, March 10 - For all patients with stable coronary artery disease (CAD), the goal of therapy should be to get LDL cholesterol lower than 70 mg/dL, said Christie Ballantyne, M.D., director of the center for cardiovascular disease prevention at Baylor College of Medicine in Houston.

Mar 22, 2006